G. Barone

Efficacy outcomes and prognostic factors from real-world patients with advanced non-small-cell lung cancer treated with first-line chemoimmunotherapy: The Spinnaker retrospective study.

C. Escriu, A. Addeo, J. Cave, 2022, International immunopharmacology.

Decrease of serum carnitine levels in patients with or without gastrointestinal cancer cachexia.

M. Costanzo, M. Malaguarnera, M. Cannizzaro, 2006, World journal of gastroenterology.

Pembrolizumab in performance status 2 patients with non-small cell lung cancer (NSCLC): Results of the PePS2 trial.

K. Brock, Y. Summers, G. Middleton, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

Spiramycin/cotrimoxazole versus pyrimethamine/sulfonamide and spiramycin alone for the treatment of toxoplasmosis in pregnancy

M. Ceccarelli, D. Buonsenso, P. Valentini, 2014, Journal of Perinatology.

Efficacy and safety of RAD001 in advanced biliary tract cancer (BTC) patients (pts) progressing after first-line chemotherapy: A phase II study.

M. Platania, E. Bajetta, S. Pusceddu, 2010 .

Pembrolizumab in patients with non-small-cell lung cancer of performance status 2 (PePS2): a single arm, phase 2 trial.

L. Billingham, K. Brock, S. Lee, 2020, The Lancet. Respiratory medicine.

Bifidobacterium longum with Fructo-Oligosaccharide (FOS) Treatment in Minimal Hepatic Encephalopathy: A Randomized, Double-Blind, Placebo-Controlled Study

M. Malaguarnera, M. Malaguarnera, M. A. Toscano, 2007, Digestive Diseases and Sciences.

The Effects of GCSF Primary Prophylaxis on Survival Outcomes and Toxicity in Patients with Advanced Non-Small Cell Lung Cancer on First-Line Chemoimmunotherapy: A Sub-Analysis of the Spinnaker Study

C. Escriu, A. Addeo, J. Cave, 2023, International journal of molecular sciences.

Single agent panitumumab in KRAS wild-type metastatic colorectal cancer patients following cetuximab-based regimens

F. D. De Braud, F. Perrone, A. Lampis, 2013, Cancer biology & therapy.

Immunotherapy-related adverse events in real-world patients with advanced non-small cell lung cancer on chemoimmunotherapy: a Spinnaker study sub-analysis

C. Escriu, A. Addeo, J. Cave, 2023, Frontiers in Oncology.